Last reviewed · How we verify
NCT03832309
Techniques to Reduce the Severity and Frequency of Emergent Reactions
NA trial testing Do we speak to them in a way that convinces them to have the dream in Analgesia in 38 participants. Terminated before completion.
21 June 2021
Quick facts
| Lead sponsor | CHRISTUS Health |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 38 |
| Start date | 21 November 2017 |
| Primary completion | 21 June 2021 |
| Estimated completion | 21 June 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Do we speak to them in a way that convinces them to have the dream
- Speaking to them as a regualar person
Conditions studied
- Analgesia — all drugs for Analgesia →
Sponsor
CHRISTUS Health — full company profile →
Who can join
18 and older, any sex, with Analgesia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objectives of this study are first to determine if the power of suggestion will decrease the frequency and severity of emergence reactions after procedural sedation and analgesia with ketamine in the setting of the emergency department. Second, to determine if people dream about what they were thinking about when they were induced with ketamine.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03832309
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Analgesia
Currently open trials in the same condition.
- NCT07249827 — A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guid · Phase 2 · recruiting
- NCT07250230 — Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Un · NA · recruiting
- NCT07337629 — Single Dose Preemptive Paracetamol or Ibuprofen Before Septrorhinoplasty on Intra- and Postoperative Opioid Consumption. · recruiting
- NCT07310953 — Clinical Utility of the Numerical Verbal Scale (NVS) and the Pain and Functional Activity Scale (PFAS) in the Management · NA · recruiting
- NCT06869967 — Evaluation of Postoperative Pain Control in Ear Surgery · NA · recruiting
Other CHRISTUS Health trials
Trials by the same sponsor.
- NCT06726811 — Droperidol and QTc Interval Changes in ED Patients · recruiting
- NCT06555315 — Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic) · NA · recruiting
- NCT06589284 — Skin Glue Versus Suture for Securing Radial Arterial Lines · NA · completed
- NCT04869579 — Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients. · Phase 2 · unknown
- NCT06059417 — Foam Tape Allergy a Sticky Situation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03832309 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CHRISTUS Health
- Last refreshed: 6 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03832309.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing